Welcome to #1 DIGITAL HEALTH NEWS Portal

Abbott Announces New Data that Shows Artificial Intelligence Technology can Help Doctors Better Determine which Patients are Having a Heart Attack

Abbott (NYSE: ABT) announced that new research, published in the journal Circulation, found its algorithm could help doctors in hospital emergency rooms more accurately determine if someone is having a heart attack or not, so that they can receive faster treatments or be safely discharged.

Read more ...

MEDICA Becomes Number One Trade Fair for Health Start-Ups too

18 - 21 November 2019, Düsseldorf, Germany.
Healthcare is going digital worldwide at an incredibly rapid pace. More and more applications for prevention, diagnostics and therapy are being made into apps (with matching hardware) for smartphones and tablets or are even available as wearables for direct use on the body.

Read more ...

Being Open about Open Source

Opinion Article by Shane Tickell, Chief Executive, IMS MAXIMS
IMS MAXIMS entered whole heartedly into the open source arena by releasing our code in 2014; but since then market conditions have changed. Despite this, we have not abandoned the project. In fact, we remain fully committed to it and optimistic that the new team at NHSX will recognise its value. Let me explain.

Read more ...

Medical Informatics Europe Conference 2019 (MIE 2019)

28 April - 1 May 2020, Geneva, Switzerland.
The European Federation of Medical Informatics (EFMI) presents the 30th Medical Informatics Europe conference (MIE) at the Geneva International Conference Center (CICG). This conference is organized in partnership with the World Health Organization (WHO), the International Telecommunication Union (ITU), the State of Geneva (Geneva), the University of Geneva (UNIGE) and the University Hospitals of Geneva (HUG).

Read more ...

The Future of Mind Control

Electrodes implanted in the brain help alleviate symptoms like the intrusive tremors associated with Parkinson's disease. But current probes face limitations due to their size and inflexibility. "The brain is squishy and these implants are rigid," said Shaun Patel. About four years ago, when he discovered Charles M. Lieber's ultra-flexible alternatives, he saw the future of brain-machine interfaces.

Read more ...

International HL7 Interoperability Conference 2019

22 - 24 October 2019, Warsaw, Poland.
19th International HL7® Interoperability Conference (IHIC) will be held in Warsaw, Poland. The event, organized by HL7 Poland, will focus on implementation of healthcare interoperability standards, with special interest in project specifications like implementation guides and profiles, in conformance validation and testing.

Read more ...

St Helens and Knowsley Advance with Ambitious Digital Transformation Programme

St Helens and Knowsley Teaching Hospitals NHS Trusthas successfully gone live with System C’s CareFlow Vitals as part of its ambitious strategy to accelerate digitisation and become a digital exemplar using System C’s hospital and care community-wide blueprint.

Read more ...

UKCloud Health selected by NHS Shared Business Services to Provide Multi-Cloud Services on its New Cloud Solutions Framework

UKCloud Health, the multi-cloud experts dedicated to powering the Healthcare community, has today announced that it has been awarded a place on all 4 lots of the new NHS Shared Business Services Cloud Solutions framework which runs for initial 2-year term with the option to extend to 2023.

Read more ...

Solutions Architect - Patients Data

You'll work in Science IT. In the era of digital health, AI and big data, IT is a groundbreaking partner in making digital R&D a reality. Improving the way that our medicines can help our patients is a constant driver for AstraZeneca, and our IT capabilities are vital in analysing and interpreting the clinical trials and real-world data that allow the right decisions to be made.

Read more ...

Experimental Validation Confirms the Ability of Artificial Intelligence to Accelerate Drug Discovery

Insilico Medicine, a global leader in artificial intelligence for drug discovery, today announced the publication of a paper titled, "Deep learning enables rapid identification of potent DDR1 kinase inhibitors," in Nature Biotechnology. The paper describes a timed challenge, where the new artificial intelligence system called Generative Tensorial Reinforcement Learning (GENTRL) designed six novel inhibitors of DDR1, a kinase target implicated in fibrosis and other diseases, in 21 days.

Read more ...